LSI USA '25 Almost at Capacity: Register Today arrow-icon

Overview

Valued at ~$1.45 billion in 2023, the percutaneous revascularization devices market is projected to reach ~$4.19 billion by 2028, increasing at a CAGR of 23.6% over the 2023-2028 forecast period. This Market Snapshot is part of LSI’s Market Intelligence platform, your one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and deal-tracking, curated insights, and more.
Percutaneous revascularization devices are catheter-based tools used to treat atherosclerosis, a condition where arteries narrow and restrict blood flow. These devices work by modifying plaque within the vessel, which helps widen the artery and improve blood circulation. These devices are one of many solutions available to prepare and revascularize occluded vessels. This analysis focuses on catheter-based revascularization devices, excluding angioplasty balloons, another commonly used treatment option.
Products included within the scope of this analysis include:
Directional atherectomy
Laser atherectomy
Orbital atherectomy
Laser atherectomy
Intravascular lithotripsy (IVL)
This Market Snapshot is intended to provide a high-level overview of the global market for percutaneous revascularization devices, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups

Percutaneous Revascularization Devices Market Snapshot Summary

Snapshot Aspect Data and Details
Base Year for Estimate 2023
Forecast Period 2023 - 2028
Market Size in 2023 $1.45 billion
CAGR 23.6%
Projected Market Size in 2028 $4.19 billion

Percutaneous Revascularization Devices Market Insights

The percutaneous revascularization devices market has experienced substantial growth, driven by innovations like IVL, which has become an essential technique for managing calcified lesions. The adoption of IVL—particularly the Shockwave Medical IVL device—has significantly reshaped the market, with Shockwave becoming the largest supplier in the atherectomy/plaque modification device market by revenue in 2022. This market has expanded to $1.45 billion in 2023, a nearly three-fold increase since Shockwave’s entry in 2016.
The shift from traditional atherectomy devices to IVL has significantly changed the market’s pricing dynamics, as IVL catheters, such as the Shockwave device, are priced significantly higher—up to four times more than conventional atherectomy catheters. This shift reflects the growing clinical acceptance of IVL for plaque modification, positioning it as a dominant solution in the revascularization devices market.

Competitive Landscape

The full Market Snapshot includes a robust analysis of the competitive landscape for the percutaneous revascularization devices market. This includes estimated market revenue and market share for key players, such as Shockwave Medical, Cardiovascular Systems, and Medtronic.
Percutaneous revascularization devices market competitor breakdown.

Select Market Events

Company Date Type Event
Johnson & Johnson
5/2024 M&A J&J completed its acquisition of Shockwave Medical, the current market leader for atherectomy devices.

Key Companies Covered

Amplitude Vascular Systems
Boston Scientific
Cardiovascular Systems
FastWave Medical
Johnson & Johnson
Rex Medical
Shockwave Medical
Sonosemi Medical
Vantis Vascular

Order individually or subscribe and
get a complete intel platform.

Trusted By The Companies Pioneering What’s Next